SWAV - Needham likes GW Pharma in premarket analyst action October, 21 2019 08:55 AM ShockWave Medical Inc. Axonics Modulation Technologies (NASDAQ:AXNX) initiated with Overweight rating and $43 (110% upside) price target at Barclays.More news on: Axonics Modulation Technologies, Inc., GW Pharmaceuticals plc, ShockWave Medical, Inc., Healthcare stocks news, Stocks on the move, , Read more ...